Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
L-779450
Cat. No.:
OB0225LY-0369
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Product Overview
Description:
L-779450 is a selective tyrosine kinase inhibitor.
Synonym:
L 779450; 303727-31-3; 2-Chloro-5-(2-phenyl-5-(pyridin-4-yl)-1H-imidazol-4-yl)phenol; Phenol, 2-chloro-5-[2-phenyl-4-(4-pyridinyl)-1H-imidazol-5-yl]-; 2-Chloro-5-(2-phenyl-4-(pyridin-4-yl)-1H-imidazol-5-yl)phenol
CAS No.:
303727-31-3
Compound CID:
9950176
Formula:
C20H14ClN3O
Formula Weight:
347.8
Specification
Relative Density:
1.335 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
L-779450 can be used for cancer signaling pathway research or play an important role in drug development.
Library Information
Targets:
Raf; Autophagy
Receptors:
Autophagy; Raf
Pathways:
Autophagy; MAPK
Plate Number:
AOCL-5
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 172.51 mM
